Medable Inc Executives on Innovative Decentralized Clinical Trials | Interview

2 years ago
1

Join The Conversation! | https://trialsitenews.com/
Medable Inc is a leading platform for patient-centered clinical research and just announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials. Dr. Pamela Tenaerts , chief scientific officer and Sanskriti Thakur , chief growth officer, discuss how Medable is innovating the world of decentralized clinical trials.

Loading comments...